SHARE-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Summary of restricted common stock transactions
The following table summarizes the Company's restricted common stock transactions:
 
Non-Employee Directors
 
Non-Employees
 
Employees
 
Total
Unvested shares as of January 1, 2015
12,301

 
453,213

 
40,396

 
505,910

Issued
13,896

 
250,390

 
43,326

 
307,612

Vested
(10,930
)
 
(81,281
)
 
(21,561
)
 
(113,772
)
Forfeited

 
(4,665
)
 
(3,716
)
 
(8,381
)
Unvested shares as of December 31, 2015
15,267

 
617,657

 
58,445

 
691,369

Schedule of restricted stock granted
The following table summarizes the restricted common stock grants during the year ended December 31, 2015:
Date
 
Shares
 
Vesting/Year
 
Date(s)
February 3, 2015
 
1,819
 
100%
 
2/3/16
February 5, 2015
 
241,524
 
33.3%
 
2/5/16, 2/5/17, 2/5/18
February 5, 2015
 
28,818
 
33.3%
 
2/5/16, 2/5/17, 2/5/18
March 9, 2015
 
8,047
 
100%
 
3/9/16
March 12, 2015
 
1,906
 
100%
 
3/12/16
March 31, 2015
 
8,841
 
100%
 
5/15/16 (1)
June 8, 2015
 
2,124
 
100%
 
6/8/16
August 10, 2015
 
14,503
 
100%
 
3/31/16, 3/31/17, 3/31/18
September 1, 2015 (2)
 
30
 
various
 
various

(1)
In connection with a grant of restricted common stock made on September 24, 2014, the Company agreed to issue up to 17,682 additional shares of common stock if certain commercial real estate loan origination performance thresholds were achieved by personnel from the Company’s commercial real estate loan origination team.  The performance criteria are measured at the end of two annual measurement periods which began April 1, 2014.  The agreement also provided dividend equivalent rights pursuant to which the dividends that would have been paid on the shares had they been issued on the date of grant were paid at the end of each annual measurement period if the performance criteria were met.  If the performance criteria are not met, the accrued dividends are forfeited.  As a consequence, the Company did not record the dividend equivalent rights until earned.  On March 31, 2015, the first annual measurement period ended and 8,841 shares were earned.  These shares will vest over the subsequent 12 months at a rate of one-fourth per quarter. In addition, approximately $21,000 of accrued dividend equivalent rights were earned and paid. As of December 31, 2015, it was determined that the performance criteria for the final 8,841 shares were earned prior to the end of the measurement period, March 31, 2016. As of December 31, 2015, $42,000 of accrued dividend equivalent rights were accrued and will be paid in April 2016. These performance shares will vest over the subsequent 12 months at a rate of one-fourth per quarter.
Summary of stock option transactions
The following table summarizes the Company's preferred stock:
 
Year ended December 31, 2015
 
Total Outstanding
 
Number of Shares Sold
 
Weighted Average Offering Price
 
Number of Shares
 
Weighted Average Offering Price
8.50% Series A Preferred Stock

 
$

 
1,069,016

 
$
24.05

8.25% Series B Preferred Stock
139,333

 
$
22.34

 
5,740,479

 
$
23.81

8.625% Series C Preferred Stock

 
$

 
4,800,000

 
$
25.00

The following table summarizes the status of the Company’s vested stock options as of December 31, 2015:
Vested Options
 
Number of Options
 
Weighted Average Exercise Price
 
Weighted Average Remaining Contractual Term (in years)
 
Aggregate Intrinsic Value (in thousands)
Vested as of January 1, 2015
 
160,167

 
$
57.80

 
 
 
 
Vested
 

 
$

 
 
 
 
Exercised
 

 
$

 
 
 
 
Forfeited
 

 
$

 
 
 
 
Expired
 
(133,917
)
 
$
60.00

 
 
 
 
Vested as of December 31, 2015
 
26,250

 
$
46.60

 
3.20
 
$

Summary of share based compensation expense
The components of equity compensation expense for the periods presented are as follows (in thousands):
 
December 31,
 
2015
 
2014
 
2013
Options granted to Manager and non-employees
$

 
$
(2
)
 
$
6

Restricted shares granted to non-employees
2,163

 
5,679

 
10,142

Restricted shares granted to employees
725

 
633

 
106

Restricted shares granted to non-employee directors
257

 
256

 
218

Total equity compensation expense
$
3,145

 
$
6,566

 
$
10,472